Summary Information about occurrence of testicular cancer (TC) 
Familial testicular cancer (TC) although rare, is a well documented entity. There are numerous reports in the literature of families with two or more affected members. Two reports have estimated the relative risk to first-degree relatives of TC cases to be between 6 and 10 (Tollerud et al., 1985; Forman et al., 1992) . This estimate is considerably higher than that for most common cancers in which it rarely exceeds 4 (Forman et al., 1992) . The proportion of TC that is familial is, however, considered to be very low (0.2-2.2% of cases) (Dieckmann et al., 1987) .
We have established a database on all TC patients treated at the Norwegian Radium Hospital, Oslo, Norway and University Hospital Lund in Sweden over more than 10 years. In this paper, we give details of clinical data and family history of all evaluable patients, compare clinical characteristics of patients with familial and sporadic TC and estimate the relative risk to first-degree relatives of TC patients.
Materials and methods
The Norwegian patient cohort consists of 895 consecutive patients referred for post-orchiectomy treatment for testicular germ cell tumour (TC) at the Norwegian Radium Hospital (NRH) from January 1981 to June 1991 and 27 patients treated at Haukeland University Hospital in Bergen in the same period. The NRH today serves as the only oncology centre giving post-orchiectomy treatment to approximately half the Norwegian population of 4.2 million. During the early 1980s, when oncology services were being established in other parts of the country, the NRH also treated a major proportion of TC patients from other areas. We have, however, no indication of a selective referral to the NRH on the basis of positive family history of TC or other cancers.
We obtained information about cancer in the families of all surviving patients who could be located by means of a questionnaire. Patients were asked to list the year of birth and year of cancer diagnosis/year of death if applicable for all first-degree relatives and grandparents. In addition, we asked for cases of testicular cancer in more distant relatives. Using the same methods, family history of cancer was obtained from all available patients treated at the University Hospital Lund in southern Sweden during the same period (n=237). This hospital gives oncological treatment to all TC cases seen in a defined geographical region in southern Sweden.
As this study deals with the number of families of testicular cancer patients rather than the number of patients, adjustment was made for double ascertainment of families. This occurred in eight Norwegian and two Swedish families, which was ascertained through two members with TC diagnosed during the accrual period. Members of these families were counted twice in the calculations of standardized incidence ratios (SIRs).
In n-30 n-31 n-32 n-34 n-46 n-48b n-51 n-63b n-3a n-6b n-7b (Table I) . Thus, the frequency of familial cases was 4.8%. About half of the familial cases had an affected firstdegree relative (32/1159=2.8%). The percentage of patients with an affected first-degree relative was similar in the Norwegian and Swedish patients (27/922 = 2.9% and 5/ 237=2.1% respectively). Only Norwegian patients reported TC in more distant relatives (n = 24).
The 1081 patients belonged to 1071 families, of which 46 were defined as testicular cancer families with two or more affected relatives. Forty-three families had two affected members and three families had three affected members (families n-10, n-24 and n-43). In addition, family n-10 possibly had a fourth affected member in that a maternal uncle was reported to have had TC in 1948. This cancer is, however, not confirmed. The pedigrees of the three families with three affected members are shown in Figure 1 . Details of the familial cases are given in Table I .
In the questionnaire 29 patients reported a first-degree relative, 15 patients a second-degree relative, seven patients a cousin, and three patients a more distant relative with germ cell tumour, including one proband who reported both an uncle and a cousin with the disease. The brother pairs include one pair of monozygotic twins, in whom three seminomas were discovered simultaneously. No brother had childhood TC. SIRs for first-degree relatives are given in Table II . Two patients reported a paternal grandfather with TC. Both grandfathers had the disease before 1953. Eight patients had an affected uncle and four patients an affected nephew (including one nephew with extragonadal germ cell tumour, Table I ). In addition, one proband had an affected double cousin. Seven patients had one affected first cousin (Table T) .
In an additional patient we confirmed the presence of two maternal cousins (family n-10) with the disease and, in family n-30, the son of the mother's brother had TC during 1993. A final three patients had one or more distant relatives with TC (Table I) . Closed squares denote affected males, arrows indicate probands.
Fdllllly 11-FO. In addition to the familial cases ascertained through the questionnaire, familial TC is known to have occurred in four Norwegian families. One brother was diagnosed with testicular cancer during 1993 (family n-63, Table I ) and two patients who have not answered the questionnaire are known to have a father and a brother respectively, with the disease (families n-6 and n-48, Table I ). Finally, twin brothers who are second cousins of a proband that did not respond to the questionnaire both had TC during 1994 (family n-53). The latter cases occurred after the completion of the data analysis and the proband is included as a sporadic case in all calculations.
In the Norwegian data set we calculated the cumulative risk to brothers of having TC (Figure 2 ). The point estimate of the risk at 50 years of age was 2.8% (95% CI 1.2-4.4%) rising to 4.1% (95% CI 1.7-6.6%) at age 60. The calculated increase in risk between ages 50 and 60 is based on only two cases, one of which developed a spermatocytic seminoma at age 58.
Clinical details of the Norwegian familial cases Bilaterality Five out of 51 probands with familial TC had bilateral tumours (9.8%, 95% CI 3.1-22.9%). Four out of five contralateral tumours were seminomas (two synchronous and two asynchronous). Correspondingly, 24/871 (2.8%, 95% CI 1.8-4.1%) patients with sporadic TC had contralateral germ cell tumours. Thus, the proportion of patients with bilateral tumours was significantly higher in familial than sporadic TC (P=0.02, Fisher's exact one-tailed test).
Histology There were 33 pure seminomas (58.9%) including one spermatocytic seminoma, six combined tumours and 17 pure non-seminomas among the probands with familial tumours. Among the sporadic cases, 448/892 (50.2%) tumours with known histological subclassification were seminomas. Counting combined tumours with the nonseminomas the distribution of histological types in the probands is not different from that of the non-familial cases (chi-square with Yates' correction 1.27, P= 0.26).
Age of diagnosis The median age of the probands with familial tumours at (first) orchiectomy was 32.6 years (range 17.9-71.8 years). Median age in the group of sporadic cases was 32.7 years (14.5-81.8 years). The age of the probands that were fathers/uncles (n=6) was 45.8 years (range 28.8-71.8 years), while the age of remaining probands (n=45) was 31.7 years (range 17.9-58.1 years). This difference is statistically significant (P=0.02, Mann-Whitney U-test). The age distribution of the probands with familial tumours (excluding the fathers and uncles) was not significantly different from that of sporadic cases (P= 0.57, MannWhitney U-test).
As there were slightly more seminomas in the probands with familial TC than in the sporadic cases, age at orchiectomy was calculated separately for each histological subgroup. Median age for seminomas was lower in the familial cases when excluding probands that were fathers or uncles than in sporadic cases (32.9 vs 37.6 years) and somewhat higher in the non-seminomas (29.2 vs 28.1 years). The difference in median age of onset was of borderline statistical significance in seminomas (P= 0.06, MannWhitney U-test).
In the familial cases there are seven father-son pairs. The sons had a lower median age at orchiectomy (28.8 years, range 19.0-44.2 years) than their fathers (44.9 years, range 35.9-59.2 years). This difference was statistically significant (P= 0.04, one-tailed Wilcoxon signed-rank test for paired data).
Undescended testis (UDT) The prevalence of UDT was calculated from information obtained by questionnaire and/ or patients records. UDT had been present in 4/49 (8.2%) probands with familial TC and in 107/804 (13.3%) sporadic cases with known status as to testicular descent. The difference is not statistically significant.
Discussion
Our estimate of the proportion of familial cases in TC was 4.8%. The proportion of familial cases in the Norwegian part of the study is considerably higher than in the Swedish part. The discrepancy is due to the absence of testicular cancers in distant relatives in the Swedish patients and the presence of such cases in Norway. It seems unlikely that there are separate risk factors in the two countries restricting the excess risk in Swedes to first-degree relatives, and we believe the discrepancy may be due to underreporting of cases in distant relatives in Sweden. Forman et al. (1992) in TC patients from the UK when excluding the older generation to correct for ascertainment bias. In the present data set we found the age difference to be present only in seminomas. In nonseminomas, the familial cases had a higher age at orchiectomy than did the sporadic cases. If our finding of no difference in age of onset is correct, it may imply that the genetic factor(s) of importance, at least for non-seminomas, does not follow the Knudson two-hit model and thus that the gene(s) involved is not a classical tumour-suppressor gene. However, there may be other explanations for our findings. In particular, since TC affects young men who have not completed their reproductive period, complex mechanisms leading to ascertainment bias may be present.
The prevalence of UDT in the familial cases was not different from that of the sporadic cases. Taken together with data from the literature (Forman et al., 1992; Tollerud et al., 1985) , this suggests that the risk from being related to a TC patient is not dependent on the risk conferred by UDT.
